Give Green, Get Green

Give Green, Get Green for Arthritis

While St. Patrick’s Day might be months away, Arthritis Foundation supporters in nine different markets are painting the town green in honor of over 50 million Americans and 300,000 kids living with arthritis.

The Arthritis Foundation recently launched the fall Give Green, Get Green for Arthritis fundraising campaign to generate awareness and raise vital funds to find a cure for arthritis. The Give Green, Get Green campaign has kicked off in New York City (NY), Baltimore (MD), Louisiana, Montgomery (AL), South Florida, Cleveland (OH), Cincinnati (OH), Phoenix (AZ) and Minneapolis (MN). Local markets are looking to recruit “Champion Greenies” who can raise a minimum of $1,500 by engaging their network, staff, colleagues, friends and family.

Continue reading Give Green, Get Green for Arthritis

ibuprofen risk

Ibuprofen May Raise Heart Risk More Than Other NSAIDs

A big study published in 2016, called the PRECISION trial, found that people with arthritis who take the anti-inflammatory drug ibuprofen are more likely to develop cardiovascular problems than those using celecoxib – and now researchers think they know why. Ibuprofen raises blood pressure, according to new findings presented recently at the annual meeting of the European Society of Cardiology in Barcelona.

Continue reading Ibuprofen May Raise Heart Risk More Than Other NSAIDs

fifth arthritis biosimilar

FDA Approves A Fifth Biosimilar for Arthritis, But Three Are Still Not Available

The number of biosimilars approved by the Food and Drug Administration (FDA) continues to grow in the United States, and they are slowly becoming available to consumers.

In late August, the FDA approved Cyltezo (adalimumab-adbm), a second biosimilar to Humira (adalimumab). But like the first biosimilar, Amjevita (adalimumab-atto), which was approved in September 2016, it is not yet available to U.S. consumers because of pending patent litigation with AbbVie, the manufacturer of Humira.

Continue reading FDA Approves A Fifth Biosimilar for Arthritis, But Three Are Still Not Available

charitable gift annuity

Benefit From a Charitable Gift Annuity While Doing Good

You’ve worked hard for decades – and it’s about time to enter the next phase of your life. You’ll have time to catch up on those books you’ve been meaning to read, travel to places you’ve dreamed of visiting and perhaps volunteer for that charity you’ve always admired.

But a pleasurable retirement requires sound financial planning. How can you be sure you’ll continue receiving the lifetime income you need and not have to worry that you’ll have enough?

Continue reading Benefit From a Charitable Gift Annuity While Doing Good

hurricane irma preparedness

Preparing for Irma if You Have Arthritis

During a natural disaster, not having your medications or assistive devices adds to physical and emotional stress, which can trigger arthritis flares and leave you vulnerable to injury and infection.  

“High stress levels make rheumatic conditions worse; having an established emergency plan can only reduce stress,” says Jennifer Hootman, PhD, an epidemiologist in the Arthritis Program at the Centers for Disease Control and Prevention in Atlanta, Georgia. Registered nurse Victoria Ruffing, director of nursing and patient education at the Johns Hopkins Arthritis Center in Baltimore, MD, also stresses the need to have a plan for your medications – and awareness of the potential dangers for people with arthritis of the storm’s aftermath.

“Contaminated water, debris, and other post-hurricane conditions mean environments are ripe for infection and injury,” she says. “People should be on the alert for these and, if they pick up a bacterial or viral infection or have a wound that’s not healing well, they should seek medical care as soon as possible. This will probably mean going to an emergency department, but they should not put off seeking care – in disaster conditions medical problems can get worse very quickly.”  

Continue reading Preparing for Irma if You Have Arthritis

pain awareness month

September Is Pain Awareness Month

September is Pain Awareness Month – when we raise public awareness about the chronic pain nearly 100 million Americans experience and ways to effectively manage it.

Everyone has acute pain from time to time, typically coming from an injury, like cutting a finger or pulling a muscle; usually the pain goes away within 30 days or once the injury heals. Chronic pain, on the other hand, persists or progresses; your body keeps hurting for weeks, months or even years.

If you have arthritis, you may experience chronic pain.

Continue reading September Is Pain Awareness Month

dr richard loeser jr - arthritis research

Researchers on the Path to a Cure – Spotlight on Dr. Richard F. Loeser, Jr

“You are what you eat” is a phrase we often hear. But how true is it? Dr. Richard F. Loeser, Jr. and his research team are looking at the role of diet in their Arthritis Foundation-funded project “The Role of the Microbiome in Metabolic Osteoarthritis (OA)”.

Different factors play into why a person develops OA, including aging, injury, and being overweight. Diet plays an important role. What you eat can help influence what bacteria (or microbiota) live in your digestive track (gut). This, in turn, can influence what chemicals are released into your body. A healthy gut generally has a more diverse collection of helpful microbiota, while a microbial imbalance can lead to disease.

Continue reading Researchers on the Path to a Cure – Spotlight on Dr. Richard F. Loeser, Jr

fibromyalgia weights

Top Fibro Treatments

If you’ve been diagnosed with mild to moderate fibromyalgia, exercise and other non-drug therapies should be your first line of treatment, according to the European League Against Rheumatism (EULAR), an international group of health professionals in rheumatology. EULAR’s updated fibromyalgia treatment recommendations, published in 2016 in Annals of the Rheumatic Diseases, are similar to the 2007 version, but this time they are based on hard evidence, which was scarce 10 years ago, rather than on expert opinions.

For the updated guidelines, researchers reviewed 107 research papers. Assessing outcomes for pain, fatigue, sleep and daily functioning, they ranked their recommendations of various therapies as “strong for,” “weak for,” “weak against” and “strong against.”

Continue reading Top Fibro Treatments

delivering on discovery

Researchers on the Path to a Cure – Spotlight on Dr. Hongsik Cho

Big things come in small packages, and Dr. Hongsik Cho is very familiar with this phenomenon. When we first introduced Dr. Cho in August 2016, he was beginning work on his 2-year Arthritis Foundation-funded project, “A Novel Method of Detecting and Treating Early PTOA Using Smart Nanosome”.  He and his team are studying two things: a new drug and a new drug delivery system.  The drug, called TPCA-1, works to prevent inflammation caused by post-traumatic osteoarthritis (PTOA).  The drug delivery system uses small packets called nanosomes that contain TPCA-1 and a fluorescent dye that illuminates the nanosomes’ path once injected into mice.

Continue reading Researchers on the Path to a Cure – Spotlight on Dr. Hongsik Cho

dr jarvis - path to a cure

Researchers on the Path to a Cure – Spotlight on Dr. James Jarvis

“Why did my child get arthritis?” This parent-driven question is at the heart of Dr. Jim Jarvis’s juvenile idiopathic arthritis (JIA) Arthritis Foundation-funded project, “Interplay between genetics and epigenetics in polyarticular JIA”.

“This is less about an illness driven by inherited genes and more about how the environment affects gene expression,” explained Dr. Jarvis. “It’s been shown that only about 30 percent of the risk for developing JIA can be attributed to gene variations.”

Continue reading Researchers on the Path to a Cure – Spotlight on Dr. James Jarvis